Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
PI3K δ 保留抑制剂 MEN1611 对 PIK3CA 突变、曲妥珠单抗耐药的 HER2 + 乳腺癌的抗肿瘤活性
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-023-06895-2
Alessio Fiascarelli, Giuseppe Merlino, Stefania Capano, Simone Talucci, Diego Bisignano, Alessandro Bressan, Daniela Bellarosa, Corrado Carrisi, Alessandro Paoli, Mario Bigioni, Patrizia Tunici, Clelia Irrissuto, Massimiliano Salerno, Joaquin Arribas, Elisa de Stanchina, Maurizio Scaltriti, Monica B